Did the HCA Healthcare CEO Get a Raise?
Yes. Sam Hazen's total compensation rose 0% to $8.0M in 2025, from $8.0M in 2024, per HCA Healthcare's SEC DEF 14A filings.
This page answers a common executive-compensation question: Did the HCA Healthcare CEO Get a Raise?. The answer draws on SEC DEF 14A proxy statements, the public disclosure mechanism for U.S. public-company executive pay. Every public company must file an annual proxy statement disclosing CEO and named-executive-officer compensation in detail. Why this matters for shareholders: executive compensation is the single most-disclosed governance metric at U.S. public companies, and the Dodd-Frank-mandated say-on-pay vote gives shareholders an explicit channel to express approval or dissent. Reading pay data well — including pay-versus-performance, peer-group selection, and time-vesting structures — is a basic part of stock-by-stock fundamental analysis.
The detailed answer below uses the actual proxy-statement filings, explains how to read them, and translates the executive-compensation accounting into the shareholder-relevant interpretation.
Sam Hazen Pay: 2024 → 2025
- 2025 total comp
- $8,020,000
- 2024 total comp
- $8,000,000
- Change ($)
- +$20,000
- Change (%)
- +0%
Source: HCA Healthcare SEC DEF 14A proxy statements, 2024 and 2025 Summary Compensation Tables.
In its latest proxy statement, HCA Healthcare reported Sam Hazen's 2025 total compensation at $8,020,000 — up $20,000 (0%) from $8,000,000 in 2024.
Across the disclosed history, Sam Hazen's total pay has run: 2022, $8.0M; 2023, $8.0M; 2024, $8.0M; 2025, $8.0M. CEO compensation is lumpy year to year because equity grants — the largest component — are often awarded in multi-year blocks rather than evenly, so a single year's jump or drop can reflect grant timing as much as a change in pay philosophy.
Whether a raise is warranted ties back to performance: HCA Healthcare posted a 13.5% three-year total shareholder return on 7.9% revenue growth, and the package carries a CEOPay Pay-for-Performance grade of B (71/100).
Compensation Detail
| Component | Amount |
|---|---|
| Total Compensation | $8,020,000 |
| Base Salary | $802,000 |
| Stock Awards | $4,010,000 |
| Option Awards | $962,400 |
| Non-Equity Incentive | $1,203,000 |
| CEO-to-Worker Pay Ratio | 178:1 |
| Pay-Performance Grade | B |
Frequently Asked Questions
Yes. Sam Hazen's total compensation rose 0% to $8.0M in 2025, from $8.0M in 2024, per HCA Healthcare's SEC DEF 14A filings.
Sam Hazen, CEO of HCA Healthcare, earned $8.0M in total compensation in 2025, including $4.0M in stock awards and $802,000 in base salary.
In 2025, total compensation of $8,020,000 was composed of $802,000 base salary, $0 cash bonus, $4,010,000 stock awards, $962,400 option awards, and $1,203,000 in non-equity incentive compensation.
Our Pay-for-Performance Score rates HCA Healthcare as B (71/100), based on three-year total shareholder return of 13.5%, revenue growth of 7.9%, and shareholder say-on-pay vote approval.
Sam Hazen is the chief executive officer of HCA Healthcare (HCA).
More about HCA Healthcare
Yes. Sam Hazen's total compensation rose 0% to $8.0M in 2025, from $8.0M in 2024, per HCA Healthcare's SEC DEF 14A filings.
Source: SEC EDGAR DEF 14A proxy statements, 2026.